Statins may reduce mortality and severity of Covid-19 in hypertensive or heart disease patients |
Editorial
eMediNexus Coverage from: 
Statins may reduce mortality and severity of Covid-19 in hypertensive or heart disease patients
Dr Surya Kant, Professor and Head, Dept. of Respiratory Medicine, KGMU, UP, Lucknow. National Vice Chairman IMA-AMS,  18 July 2021
Coronavirus Live Count Map India

remove_red_eye 1705 Views
COVID-19 Vaccine Updates

Coronavirus Protocols

#Multispeciality

5 Read Comments                

New research has shown that Covid-positive patients, especially the hypertensive patients and those with heart disease, who had been taking statins before being hospitalised for Covid-19 had far less probability of dying.These findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry were published July 15, 2021 in the journal PLoS One. All consecutive adult patients hospitalized from January 2020 through September 2020 with active Covid-19 disease confirmed b...
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now